NFKB1 and cancer: Subsequently, IRFs 1, 3, and 7 are activated with NF-κB, which leads to the expression of type I IFN and other genes, such as ISGs; the cumulative effect of these cellular events is an antitumor immune response and cancer cell apoptosis.